ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Arizona » Infectious Disease

Top Infectious Disease Prescribers in Arizona

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
RAJIV JETLY M.D.

Infectious Disease

10,460

$532K

594
506 are 65+

6%
patients receiving schedule two controlled substances

Avg: 8%

13%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 35%

$51
Average prescription price

Avg: $235

RICHARD FELDMAN MD

Infectious Disease

3,835

$1.32M

148
22 are 65+

22%
patients receiving schedule two controlled substances

Avg: 8%

12%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

49%
prescriptions for brand name drugs

Avg: 35%

$344
Average prescription price

Avg: $235

STEPHEN KLOTZ MD

Infectious Disease

3,625

$1.61M

85
0 are 65+

21%
patients receiving schedule two controlled substances

Avg: 8%

28%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

55%
prescriptions for brand name drugs

Avg: 35%

$444
Average prescription price

Avg: $235

GLENN SCHNEPF MD

Infectious Disease

2,196

$220K

289
230 are 65+

4%
patients receiving schedule two controlled substances

Avg: 8%

9%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 35%

$100
Average prescription price

Avg: $235

LAURA SCHROEDER M.D.

Infectious Disease

1,154

$690K

244
159 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

47%
prescriptions for brand name drugs

Avg: 35%

$598
Average prescription price

Avg: $235

JOSEPH KNIGHT MD

Infectious Disease

1,127

$65.5K

63
17 are 65+

75%
patients receiving schedule two controlled substances

Avg: 8%

49%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

13%
prescriptions for brand name drugs

Avg: 35%

$58
Average prescription price

Avg: $235

HUMAIRA SHAFI M.D.

Infectious Disease

881

$331K

73
28 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

15%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

42%
prescriptions for brand name drugs

Avg: 35%

$376
Average prescription price

Avg: $235

AMARDEEP SODHI M.D.

Infectious Disease

831

$159K

274
225 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 35%

$192
Average prescription price

Avg: $235

DWIGHT CLARKE M.D.

Infectious Disease

666

$241K

83
46 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

45%
prescriptions for brand name drugs

Avg: 35%

$362
Average prescription price

Avg: $235

LARRY RUMANS MD

Infectious Disease

524

$109K

119
102 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

14%
prescriptions for brand name drugs

Avg: 35%

$208
Average prescription price

Avg: $235

JOHN LEANDER PO MD, PHD

Infectious Disease

495

$335K

53
30 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

64%
prescriptions for brand name drugs

Avg: 35%

$676
Average prescription price

Avg: $235

MIRELLA MIRCESCU M.D.

Infectious Disease

461

$489K

45
16 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

53%
prescriptions for brand name drugs

Avg: 35%

$1061
Average prescription price

Avg: $235

SHASHIKALA AMENENI M.D.

Infectious Disease

387

$99.2K

134
87 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 35%

$256
Average prescription price

Avg: $235

JOSEPH ZACHARIAH DO

Infectious Disease

353

$88.3K

96
65 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 35%

$250
Average prescription price

Avg: $235

MANDEEP RAI M.D.

Infectious Disease

243

$76.9K

60
32 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 35%

$316
Average prescription price

Avg: $235

NESTOR VARON M.D.

Infectious Disease

234

$84.8K

74
42 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

42%
prescriptions for brand name drugs

Avg: 35%

$362
Average prescription price

Avg: $235

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank